(Q42602615)

3 November 2017

Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease (English)

1 reference

3 November 2017

0 references

David S Geldmacher

1

1 reference

3 November 2017

George Provenzano

2

1 reference

3 November 2017

Thomas McRae

3

1 reference

3 November 2017

Vera Mastey

4

1 reference

3 November 2017

John R Ieni

5

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Journal of the American Geriatrics Society

3 November 2017

1 reference

3 November 2017

51

1 reference

3 November 2017

7

1 reference

3 November 2017

937-944

1 reference

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years

3 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

Dementia: the experience of family caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

Factors determining the decision to institutionalize dementing individuals: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

Longitudinal study of death and institutionalization in patients with primary degenerative dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2389.2003.51306.X

10.1046/J.1365-2389.2003.51306.X

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference